CNBC's Geoff Cutmore says the top concern of IMF and World Bank members is the outcome of the French election, and its impact on the future of the EU.
David Rubenstein, co-founder and co-CEO at The Carlyle Group, reveals what he thinks is the biggest risk for the global economy.
The EPA claims only 9 states in the U.S. report safe lead levels in their water supply, an issue causing serious public health concerns.
The EPA claims 41 states in the U.S. have heightened lead levels in their water supply, impacting millions of lives and costing billions of dollars in damages.
Divisions over how to cope with the flood of migrants is threatening the EU's global standing. Will it diminish its ability to tackle reform?
Slaves today can sell for almost nothing, and indirectly make corporations billions of dollars. Modern-day abolitionists are fighting back.
The atrocity of indentured servitude is the world's fastest-growing crime. Will a new bill passed by Obama signal the world to take notice?
A lawsuit filed by a Florida company against a billion-dollar drug firm strikes at the heart of the nationwide painkiller epidemic.
A former sales manager at Insys Therapeutics pleads guilty to charges of fraud and accepting kickbacks. CNBC's Dina Gusovsky reports.
A former sales rep for Insys Pharmaceuticals, which is under investigation in multiple US states, has pleaded guilty to federal charges of fraud.
America's addiction to painkillers is taking a toll on the workplace. Is enough being done by companies to get it under control?
The financial and socioeconomic costs of prescription painkiller abuse are showing up in the workplace.
Fighters from the former Soviet Union are joining ISIS in record numbers, according to a new report.
Nader Mousavizadeh, partner and co-founder at Macro Advisory Partners, discusses the conflict in Syria and Russian and U.S. interests.
Foreign investment funds took control of four of the country's largest banks, diluting state-owned ownership.
Greek bank stocks are being diluted as foreign vulture funds drive down stock prices. Can Greek regulators stop the hemorrhaging?
The oceans, which comprise 70% of the planet and support 2 million species, are dying. Here's 5 of the biggest challenges facing our waters.
CNBC's Dina Gusovsky provides insight to the investigation into Insys Therapeutics and its business and marketing practices. The company sells an opiate called Subsys Fentanyl Sublingual Spray.
Michael Babich, CEO of Insys Therapeutics, which is subject to several state and federal inquiries about its painkiller Subsys, is out.
How can you check how much money your doctors get from drug companies?
A look at 50 private companies set to reshape the business landscape.
A look at how leading portfolio managers and institutional investors build investment plans to meet clients’ goals.
Business icons and provocateurs share their innovative models. Learn how to upend old industries and start new ones that move markets.